Literature DB >> 25201223

Successful treatment of refractory absence status epilepticus with lacosamide.

Ulrik Sodemann1, Harald Settergren Møller, Morten Blaabjerg, Christoph Patrick Beier.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25201223     DOI： 10.1007/s00415-014-7487-4

Source DB:  PubMed          Journal:  J Neurol        ISSN： 0340-5354            Impact factor:   4.849


× No keyword cloud information.
  6 in total

1.  Lacosamide treatment of juvenile myoclonic epilepsy.

Authors:  Pegah Afra; Bola Adamolekun
Journal:  Seizure       Date:  2012-01-26       Impact factor: 3.184

2.  Lacosamide in absence status epilepticus.

Authors:  Giuseppe d'Orsi; Francesca Pacillo; Marina Trivisano; Maria Grazia Pascarella; Maria Angela Ferrara; Luigi M Specchio
Journal:  Seizure       Date:  2013-12-14       Impact factor: 3.184

Review 3.  Voltage-gated sodium channels as therapeutic targets in epilepsy and other neurological disorders.

Authors:  Massimo Mantegazza; Giulia Curia; Giuseppe Biagini; David S Ragsdale; Massimo Avoli
Journal:  Lancet Neurol       Date:  2010-04       Impact factor: 44.182

Review 4.  Lacosamide as a new treatment option in status epilepticus.

Authors:  Julia Höfler; Eugen Trinka
Journal:  Epilepsia       Date:  2013-01-07       Impact factor: 5.864

5.  A comparison of four treatments for generalized convulsive status epilepticus. Veterans Affairs Status Epilepticus Cooperative Study Group.

Authors:  D M Treiman; P D Meyers; N Y Walton; J F Collins; C Colling; A J Rowan; A Handforth; E Faught; V P Calabrese; B M Uthman; R E Ramsay; M B Mamdani
Journal:  N Engl J Med       Date:  1998-09-17       Impact factor: 91.245

6.  Intravenous lacosamide as successful treatment for nonconvulsive status epilepticus after failure of first-line therapy.

Authors:  Christoph Kellinghaus; Sascha Berning; Michael Besselmann
Journal:  Epilepsy Behav       Date:  2009-01-06       Impact factor: 2.937
  6 in total
  3 in total

Review 1.  Pharmacological Management of the Genetic Generalised Epilepsies in Adolescents and Adults.

Authors:  Linda J Stephen; Martin J Brodie
Journal:  CNS Drugs       Date:  2020-02       Impact factor: 5.749

Review 2.  Antiseizure medications in critical care: an update.

Authors:  Baxter Allen; Paul M Vespa
Journal:  Curr Opin Crit Care       Date:  2019-04       Impact factor: 3.687

Review 3.  The efficacy of lacosamide as monotherapy and adjunctive therapy in focal epilepsy and its use in status epilepticus: clinical trial evidence and experience.

Authors:  Sebastian Bauer; Laurent M Willems; Esther Paule; Christine Petschow; Johann Philipp Zöllner; Felix Rosenow; Adam Strzelczyk
Journal:  Ther Adv Neurol Disord       Date:  2016-11-29       Impact factor: 6.570
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.